Literature DB >> 25644502

Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.

C-C Tang1, G Isitman2, J Bruneau3, C Tremblay3, N F Bernard2, S J Kent1,4, M S Parsons1.   

Abstract

Natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC) has been linked to protection from HIV infection and slower progression towards AIDS. However, antibody-dependent activation of NK cells results in phenotypical alterations similar to those observed on NK cells from individuals with progressive HIV infection. Activation of NK cells induces matrix metalloproteinase (MMP)-mediated cleavage of cell surface CD16. In the present study we assessed the phenotype and functional profile of NK cells exhibiting post-activation MMP-mediated CD16 cleavage. We found that NK cells achieving the highest levels of activation during stimulation exhibit the most profound decreases in CD16 expression. Further, we observed that educated KIR3DL1(+) NK cells from human leucocyte antigen (HLA)-Bw4-carrying donors exhibit larger decreases in CD16 expression post-activation than the KIR3DL1(-) NK cell subset containing cells educated via other inhibitory receptor/ligand combinations and non-educated NK cells. Lastly, we assessed the ex-vivo expression of CD16 on educated KIR3DL1(+) NK cells and the KIR3DL1(-) NK cell subset from HLA-Bw4-carrying HIV-uninfected and HIV-infected donors. Suggestive of in-vivo activation of KIR3DL1(+) NK cells during HIV infection, CD16 expression was higher on KIR3DL1(+) than KIR3DL1(-) NK cells in uninfected donors but similar on both subsets in HIV-infected donors. These results are discussed in the context of how they may assist with understanding HIV disease progression and the design of immunotherapies that utilize antibody-dependent NK cell responses.
© 2015 British Society for Immunology.

Entities:  

Keywords:  AIDS; KIR3DL1; NK cell education

Mesh:

Substances:

Year:  2015        PMID: 25644502      PMCID: PMC4516443          DOI: 10.1111/cei.12593

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases.

Authors:  B Grzywacz; N Kataria; M R Verneris
Journal:  Leukemia       Date:  2007-02       Impact factor: 11.528

2.  Fc receptor but not complement binding is important in antibody protection against HIV.

Authors:  Ann J Hessell; Lars Hangartner; Meredith Hunter; Carin E G Havenith; Frank J Beurskens; Joost M Bakker; Caroline M S Lanigan; Gary Landucci; Donald N Forthal; Paul W H I Parren; Preston A Marx; Dennis R Burton
Journal:  Nature       Date:  2007-09-06       Impact factor: 49.962

3.  Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS.

Authors:  Nia D Banks; Nicole Kinsey; Janice Clements; James E K Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-01       Impact factor: 2.205

4.  Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.

Authors:  Leia H Wren; Amy W Chung; Gamze Isitman; Anthony D Kelleher; Matthew S Parsons; Janaki Amin; David A Cooper; Ivan Stratov; Marjon Navis; Stephen J Kent
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

5.  Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system.

Authors:  A Jewett; M Cavalcanti; J Giorgi; B Bonavida
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

6.  Human NK cell education by inhibitory receptors for MHC class I.

Authors:  Nicolas Anfossi; Pascale André; Sophie Guia; Christine S Falk; Sophie Roetynck; C Andrew Stewart; Violette Breso; Coralie Frassati; Denis Reviron; Derek Middleton; François Romagné; Sophie Ugolini; Eric Vivier
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

7.  Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.

Authors:  P F Hu; L E Hultin; P Hultin; M A Hausner; K Hirji; A Jewett; B Bonavida; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-11-01

Review 8.  Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases.

Authors:  B G Brenner; C Gryllis; M A Wainberg
Journal:  J Leukoc Biol       Date:  1991-12       Impact factor: 4.962

9.  Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.

Authors:  D S Tyler; S D Stanley; C A Nastala; A A Austin; J A Bartlett; K C Stine; H K Lyerly; D P Bolognesi; K J Weinhold
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

10.  Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.

Authors:  Anita Trundley; Helge Frebel; Des Jones; Chiwen Chang; John Trowsdale
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

View more
  11 in total

Review 1.  Beyond Viral Neutralization.

Authors:  George K Lewis; Marzena Pazgier; David T Evans; Guido Ferrari; Stylianos Bournazos; Matthew S Parsons; Nicole F Bernard; Andrés Finzi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-02-16       Impact factor: 2.205

Review 2.  Natural killer cells in HIV-1 infection and therapy.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elisa Zaghi; Clara Di Vito; Domenico Mavilio
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

3.  Role of NK Cells in Tumor Progression.

Authors:  Iñigo Terrén; Francisco Borrego
Journal:  Exp Suppl       Date:  2022

4.  Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

Authors:  Wen Shi Lee; Jonathan Richard; Marit Lichtfuss; Amos B Smith; Jongwoo Park; Joel R Courter; Bruno N Melillo; Joseph G Sodroski; Daniel E Kaufmann; Andrés Finzi; Matthew S Parsons; Stephen J Kent
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

Review 5.  Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?

Authors:  Wen Shi Lee; Matthew Sidney Parsons; Stephen John Kent; Marit Lichtfuss
Journal:  Front Immunol       Date:  2015-05-27       Impact factor: 7.561

6.  Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function.

Authors:  Martin R Goodier; Chiara Lusa; Sam Sherratt; Ana Rodriguez-Galan; Ron Behrens; Eleanor M Riley
Journal:  Front Immunol       Date:  2016-09-26       Impact factor: 7.561

7.  Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.

Authors:  Xueying Fan; Liyan Zhu; Hua Liang; Zhe Xie; Xiangbo Huang; Shuo Wang; Tao Shen
Journal:  Retrovirology       Date:  2016-11-04       Impact factor: 4.602

Review 8.  Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.

Authors:  Carlos Rosales
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

9.  Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination.

Authors:  Margaret C Costanzo; Dohoon Kim; Matthew Creegan; Kerri G Lal; Julie A Ake; Jeffrey R Currier; Hendrik Streeck; Merlin L Robb; Nelson L Michael; Diane L Bolton; Nicholas J Steers; Michael A Eller
Journal:  Nat Commun       Date:  2018-03-23       Impact factor: 14.919

Review 10.  Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.

Authors:  Stanislaw Schmidt; Lars Tramsen; Bushra Rais; Evelyn Ullrich; Thomas Lehrnbecher
Journal:  Oncotarget       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.